Literature DB >> 8550483

The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.

W Melaugh1, A A Campagnari, B W Gibson.   

Abstract

The major lipooligosaccharides of the sexually transmitted pathogen Haemophilus ducreyi 35000 have been previously found to terminate in N-acetyllactosamine and sialyl-N-acetyllactosamine, Neu5Ac alpha 2-->3Gal beta 1-->4GlcNAc (W. Melaugh, N. J. Phillips, A. A. Campagnari, M. V. Tullius, and B. W. Gibson, Biochemistry 33: 13070-13078, 1994). In this study, mass spectrometry and composition analyses have shown that the lipooligosaccharides from three other H. ducreyi strains also contain N-acetyllactosamine and are highly sialylated (approximately 30 to 50%), although one African strain was found to contain neither of these structural features.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550483      PMCID: PMC177695          DOI: 10.1128/jb.178.2.564-570.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Structural models for the cell surface lipooligosaccharides of Neisseria gonorrhoeae and Haemophilus influenzae.

Authors:  N J Phillips; C M John; L G Reinders; B W Gibson; M A Apicella; J M Griffiss
Journal:  Biomed Environ Mass Spectrom       Date:  1990-11

2.  Microscale methylation analysis of glycolipids using capillary gas chromatography-chemical ionization mass fragmentography with selected ion monitoring.

Authors:  S B Levery; S Hakomori
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Neuraminic acid is alpha 2-->3 linked in the lipooligosaccharide of Neisseria meningitidis serogroup B strain 6275.

Authors:  R Yamasaki; J M Griffiss; K P Quinn; R E Mandrell
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

4.  Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.

Authors:  M S Edwards; D L Kasper; H J Jennings; C J Baker; A Nicholson-Weller
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.

Authors:  A A Campagnari; S M Spinola; A J Lesse; Y A Kwaik; R E Mandrell; M A Apicella
Journal:  Microb Pathog       Date:  1990-05       Impact factor: 3.738

6.  Structural studies of the cell envelope lipopolysaccharides from Haemophilus ducreyi strains ITM 2665 and ITM 4747.

Authors:  E K Schweda; A C Sundström; L M Eriksson; J A Jonasson; A A Lindberg
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms.

Authors:  W Melaugh; N J Phillips; A A Campagnari; M V Tullius; B W Gibson
Journal:  Biochemistry       Date:  1994-11-08       Impact factor: 3.162

8.  Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.

Authors:  N J Parsons; P V Patel; E L Tan; J R Andrade; C A Nairn; M Goldner; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1988-10       Impact factor: 3.738

9.  Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.

Authors:  R E Schifferle; H J Jennings; M R Wessels; E Katzenellenbogen; R Roy; D L Kasper
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Haemophilus ducreyi adheres to human keratinocytes.

Authors:  R J Brentjens; S M Spinola; A A Campagnari
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.848

View more
  26 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.

Authors:  J Mbwana; I Bölin; E Lyamuya; F Mhalu; T Lagergård
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Haemophilus ducreyi is susceptible to protegrin.

Authors:  K Fortney; P A Totten; R I Lehrer; S M Spinola
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

4.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Cloning and characterization of the lipooligosaccharide galactosyltransferase II gene of Haemophilus ducreyi.

Authors:  S Sun; B Schilling; L Tarantino; M V Tullius; B W Gibson; R S Munson
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

6.  Covalent modification of Lys19 in the CTP binding site of cytidine 5'-monophosphate N-acetylneuraminic acid synthetase.

Authors:  M V Tullius; W F Vann; B W Gibson
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

7.  Molecular characterization of the interaction of sialic acid with the periplasmic binding protein from Haemophilus ducreyi.

Authors:  Thanuja Gangi Setty; Jonathan C Mowers; Aaron G Hobbs; Shubha P Maiya; Sanaa Syed; Robert S Munson; Michael A Apicella; Ramaswamy Subramanian
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

8.  Identification of a novel sialic acid transporter in Haemophilus ducreyi.

Authors:  Deborah M B Post; Rachna Mungur; Bradford W Gibson; Robert S Munson
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum.

Authors:  Alice L Erwin; Simon Allen; Derek K Ho; Paul J Bonthuis; Paul J Bonthius; Justin Jarisch; Kevin L Nelson; David L Tsao; William C T Unrath; Michael E Watson; Bradford W Gibson; Michael A Apicella; Arnold L Smith
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

10.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.